American Century Companies Inc. Sells 1,488,390 Shares of Docusign Inc. $DOCU

American Century Companies Inc. reduced its position in shares of Docusign Inc. (NASDAQ:DOCU) by 26.7% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 4,075,928 shares of the company’s stock after selling 1,488,390 shares during the period. American Century Companies Inc. owned 2.03% of Docusign worth $293,834,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of the business. NewEdge Advisors LLC grew its position in Docusign by 36.4% during the first quarter. NewEdge Advisors LLC now owns 9,202 shares of the company’s stock valued at $749,000 after buying an additional 2,457 shares during the period. AlphaQuest LLC purchased a new position in Docusign in the second quarter worth $129,000. Wealthfront Advisers LLC boosted its stake in shares of Docusign by 8.1% in the 2nd quarter. Wealthfront Advisers LLC now owns 3,983 shares of the company’s stock valued at $310,000 after purchasing an additional 297 shares in the last quarter. Envestnet Asset Management Inc. grew its holdings in shares of Docusign by 58.8% during the 2nd quarter. Envestnet Asset Management Inc. now owns 281,525 shares of the company’s stock valued at $21,928,000 after purchasing an additional 104,293 shares during the last quarter. Finally, Hantz Financial Services Inc. boosted its holdings in shares of Docusign by 106.3% during the second quarter. Hantz Financial Services Inc. now owns 848 shares of the company’s stock worth $66,000 after purchasing an additional 437 shares during the period. Institutional investors own 77.64% of the company’s stock.

Docusign Trading Down 1.4%

Shares of NASDAQ:DOCU opened at $45.07 on Friday. The company has a market cap of $9.03 billion, a PE ratio of 31.52, a price-to-earnings-growth ratio of 1.99 and a beta of 1.00. Docusign Inc. has a 12-month low of $40.16 and a 12-month high of $94.67. The stock has a 50 day moving average of $56.08 and a 200 day moving average of $66.63.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the company. Zacks Research cut Docusign from a “strong-buy” rating to a “hold” rating in a research note on Monday, November 24th. Robert W. Baird dropped their price target on Docusign from $90.00 to $75.00 and set a “neutral” rating on the stock in a research report on Friday, December 5th. Cantor Fitzgerald restated an “outperform” rating on shares of Docusign in a research note on Wednesday, December 17th. Weiss Ratings reiterated a “hold (c)” rating on shares of Docusign in a research note on Wednesday, January 21st. Finally, BTIG Research dropped their price target on shares of Docusign from $88.00 to $70.00 and set a “buy” rating on the stock in a report on Wednesday, February 18th. Five investment analysts have rated the stock with a Buy rating and sixteen have assigned a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $78.80.

Docusign News Summary

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: Nvidia CEO comments eased fears that AI will cannibalize enterprise software, sparking a session where DocuSign and other software names traded up — a sentiment boost that can help stabilize shares if sustained. DocuSign, MongoDB, Workiva, Elastic, and PagerDuty Stocks Trade Up, What You Need To Know
• Neutral Sentiment: AAII published a comparative piece weighing DocuSign vs. EverCommerce, useful for investors doing relative-value or thematic SaaS allocations but not a near-term catalyst. Which Is a Better Investment, DocuSign, Inc. or EverCommerce Inc. Stock?
• Neutral Sentiment: Reported short-interest figures for February appear to contain errors (showing 0 shares/NaN changes) and therefore offer no clear signal about bearish positioning — treat that data as unreliable until restated. (Data source summary)
• Negative Sentiment: A MarketBeat piece framing the software sell-off singled out DocuSign as exposed to AI-driven commoditization and product concentration risks, arguing the company lacks the durable moats that protect other AI beneficiaries — this narrative pressures valuations and investor confidence. AI Is Separating Software Winners From Losers, 2 Experts Explain (DOCU)
• Negative Sentiment: Commentary asking whether it’s time to reassess DocuSign after a prolonged share-price slump highlights sizable multi-timeframe declines and reinforces a cautious investor stance; such coverage can prolong negative momentum. Is It Time To Reassess DocuSign (DOCU) After Its Prolonged Share Price Slump
• Negative Sentiment: A director (Teresa Briggs) executed a small sale (~364 shares, ~$16k). The size is modest, so it’s more a datapoint than a major red flag, but insider selling can be perceived negatively in a down market. SEC Filing: Insider Sale by Teresa Briggs

Insiders Place Their Bets

In other Docusign news, CEO Allan C. Thygesen sold 26,250 shares of the stock in a transaction dated Friday, January 9th. The shares were sold at an average price of $69.60, for a total transaction of $1,827,000.00. Following the completion of the transaction, the chief executive officer owned 142,261 shares of the company’s stock, valued at $9,901,365.60. This represents a 15.58% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Robert Chatwani sold 13,818 shares of the stock in a transaction on Wednesday, December 17th. The shares were sold at an average price of $68.33, for a total transaction of $944,183.94. Following the transaction, the insider owned 70,197 shares of the company’s stock, valued at $4,796,561.01. This trade represents a 16.45% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 78,291 shares of company stock worth $5,365,134. 1.01% of the stock is owned by corporate insiders.

Docusign Company Profile

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.